This week’s EU health policy developments range from new mental health initiatives and the Pfizergate transparency case to waste disposal risks, Green Deal health impacts, and Mercosur trade concerns — all based on verified institutional sources.
This week’s EU health policy developments range from workforce pressures and medicine shortages to rare disease research, PFAS monitoring, and crisis preparedness. Key issues include newborn screening disparities, mental health, and data ethics in digital health and AI regulation.
